Dr. Wesley Hayes, Abteilungsleiter Nephrologie am Universitäts-Kinderspital Zürich

Prof. Dr.
Wesley
Hayes

Abteilungsleiter
Nephrologie
Associate Professor, University College London
Akademischer Werdegang

2004: Bachelor of Medicine, Bachelor of Surgery, University of Cambridge, UK
1998: Master of Engineering (Erste Klasse), Master of Arts, University of Cambridge, UK

Klinischer Werdegang

Seit 2024: Leiter Abteilung für Nephrologie, Universitäts-Kinderspital Zürich, Schweiz
2016-2024: Leitender Arzt Pädiatrische Nephrologie, Great Ormond Street Hospital NHS Foundation Trust, London, UK
2013-2016: Oberarzt Pädiatrische Nephrologie, Bristol Royal Hospital for Children, UK
 

Facharztausbildung

2012-2013: Fellowship pädiatrische Nephrologie, The Hospital for Sick Children, Toronto, Kanada
2008-2012: Fellowship Pädiatrische Nephrologie, Nottingham Children's Hospital, Nottingham, Vereinigtes Königreich
2006-2008: Nationales Ausbildungsprogramm - Pädiatrie, Guys & St Thomas' NHS Foundation Trust, London, Vereinigtes Königreich
2004-2006: Hausarzt - Allgemeinmedizin und Allgemeinchirurgie, Addenbrookes Hospital, Cambridge, UK

Preise und Ehrungen
  • 2023: Great Ormond Street Hospital Exceptional Member of Staff Award - winner
Tätigkeiten in Expertengremien
  • Seit 2024: International Primary Hyperoxaluria Steering Committee
  • 2022-2024: Rare Disease Collaborative Network Advisor, Primary Hyperoxaluria
  • 2017-2024: National Institute for Health and Care Excellence Clinical Expert
Mitgliedschaften
  • 2013: Amerikanische Gesellschaft für Nephrologie
  • 2012: Britische Gesellschaft für pädiatrische Nephrologie
  • 2012: Internationalen Vereinigung für Pädiatrische Nephrologie
Forschungsschwerpunkte
  • Chief Investigator of two national multi-centre clinical trials for children receiving kidney transplants:
    • PlasmaLyte Usage and assessment of kidney Transplant Outcomes in children: the PLUTO trial (EudraCT 2019-003025-22; NIHR Research for Patient Benefit grant NIHR200512)
    • A Randomised Multiple Centre Trial of Conservative versus Liberal Fluid administration for Children Receiving a Kidney Transplant (LIMITS).  NIHR Research for Patient Benefit grant NIHR38286
  • Principal Investigator for 7 International Clinical Trials for children with Primary Hyperoxaluria
Eingeworbene Drittmittel
  • 2024: National Institute for Health and Care Research, Research for Patient Benefit Programme NIHR38286: £498,329 – LIMITS trial. National multi-centre randomised controlled trial to optmimise fluid volume administration for children receiving kidney transplants
  • 2020-2023: National Institute for Health and Care Research, Research for Patient Benefit Programme NIHR200512: £349,747. National multi-centre randomised controlled trial evaluating optimal intravenous fluid for children receiving kidney transplants
  • 2015: Elizabeth Blackwell Institute: £10,000. Lung ultrasound for assessment of fluid overload in children receiving dialysis
Publikationen